ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN REAL PRACTICE: INEQUALITY OF EQUALS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Drugs based on angiotensin-converting enzyme (ACE) inhibitors have individual pharmacokinetic properties that may determine differences in the tissue concentration of ACE inhibitors and their different clinical effects.

全文:

受限制的访问

作者简介

T. Chernyavskaya

Email: corona1974@mail.ru

参考

  1. The Six Report of the Jiont National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure // Arch. Intern. Med. - 1997; 157: 2413-46.
  2. WHO - OSH Hypertension Guidelines Committee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension // J. Hypertens. - 1999; 17: 151-83.
  3. Agabiti-Rosei E., Ambrosioni E., Fimardi G. et al. Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial // Amer. J. Med. - 1992; 92: 79-83.
  4. Neal B., MacMahon S., Chapman N. Blood Pressure Lowering Treament Trialists'Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure lowering drugs: Results of prospectively designed overviews of randomised trials // Lancet. - 2000; 356: 1955-64.
  5. Heran B.S., Wong M.M., Heran I.K. et al. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension // The Cochrane Collaboration. Cochrane database of Systematic Reviews. - 2008; 4. Art. No.:CD003823.D0I:10.1002/14651858.CD003823.pub2
  6. Gerbrandt K.R., Yedinak K.C. Formulary management of ACE inhibitors // Pharmacoeconomics. - 1996; 10 (6): 594-613.
  7. Turnbull F. Blood Pressure Lowering Treatment Trialists'Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials // Lancet. - 2003; 362: 1527-35.
  8. Schwartzkopff B., Brehm M., Mundhenke M. et al. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease // Hypertension. - 2000; 36: 220-5.
  9. Thybo N.K., Stephens N., Cooper A. et al. Effect of antihypertensive treatment on small arteries of patients with previously untriated essential hypertension // Hypertension. - 1995; 25: 474-81.
  10. Филатова Н.П. Применение периндоприла (престариума) при артериальной гипертонии // Тер. арх. - 1995; 67 (9): 81-3.
  11. Asmar R., Topouchian J., Crisan O. et al. Reversion of arterial abnormalities by long-term antihypertensive therapy in large population. The Compilor study // Eur. Heart J. - 2000; 21 (Suppl.): 2366.
  12. Zannad F., Bernaud C.M., Fay R. Double-blind, randomized multicentre comparison of the effects of amlodipine and perindopril on 24-h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators’ Group // Hypertension. - 1999; 17: 137-46.
  13. Терещенко С.Н., Дроздов В.Н., Демидова И.В. и др. Ингибитор ангиотензинпревращающего фермента периндоприл при лечении застойной сердечной недостаточности // Тер. арх. - 1997; 69 (7): 53-6.
  14. Lees K.R., Reid J.L., Scott M.G. et al. Captopril versus perindopril: a double blind study in essential hypertension // Hypertension. - 1989; 3: 17-22.
  15. Grandi A.M., Venco A., Barzizza F. et al. Double-blind comparison of perindopril and captopril in hypertension: effects on left ventricular morphology and function // Hypertension. - 1991; 4: 516-20.
  16. Lees K.R., Reid J.L., Scott M.G. et al. Captopril versus perindopril: a double blind study in essential hypertension // Hypertension. - 1989; 3: 17-22.
  17. Yoshinara K., Sarut T., Abe K. et al. Clinical evalution of monotherapy with perindopril, an ACE inhibitor in the treatment of essential hypertension: double-blind parallel comparison with enalapril // Rinsho Iyaku. - 1997; 13: 4259-97.
  18. Fox K.M., Henderson J.R., Bertrand M.E. et al. The European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA) // Eur. Heart J. - 1998; 19 (Suppl. J): 52-5.
  19. Cleland J.G., Tendera M., Adamus J. et al. Perindopril for the elderly people with chronic heart failure: the PEP-CHF study // Eur. J. Heart Fail. - 1999; 1: 211-7.
  20. Baptista T. et al. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial // Schizophr. Res. - 2007; 93:99-108.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2013